Word

IN8BIO

Status

Dead

Status Code

602

Status Date

Monday, December 13, 2021

Serial Number

90099348

Mark Type

4000

Filing Date

Friday, August 7, 2020

Abandoned Date

Friday, November 26, 2021

Trademark Owner History

IN8BIO, INC. - 1st New Owner Before Publication
Incysus Therapeutics, Inc. - Original Applicant

Classifications

5 Pharmaceutical preparations, namely, oncological preparations; Reagent, diagnostic and therapeutic preparations for medical use in oncology; Targeted medical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of cancer and tumors; Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; Pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; Medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; Pharmaceutical and biological preparations comprised of modified T cells used for multiple modes of treatment against tumor resistance and immunosuppression

42 Research, development, and evaluation of new products; Pharmaceutical, medicine, and vaccine research and development services; Technical research in the field of pharmaceutical studies; Laboratory analysis and research into new drugs and pharmaceutical products; Development of scientific measuring and testing methods in the field of oncology; Design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; Research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; Providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; Scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology

44 Development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment

Trademark Events

Dec 13, 2021

Abandonment Notice E-Mailed - Failure To Respond

Dec 13, 2021

Abandonment - Failure To Respond Or Late Response

May 24, 2021

Notification Of Final Refusal Emailed

May 24, 2021

Final Refusal E-Mailed

May 24, 2021

Final Refusal Written

Apr 29, 2021

Automatic Update Of Assignment Of Ownership

Apr 28, 2021

Teas Voluntary Amendment Received

Apr 21, 2021

Teas/Email Correspondence Entered

Apr 20, 2021

Correspondence Received In Law Office

Apr 20, 2021

Teas Response To Office Action Received

Oct 20, 2020

Notification Of Non-Final Action E-Mailed

Oct 20, 2020

Non-Final Action E-Mailed

Oct 20, 2020

Non-Final Action Written

Oct 20, 2020

Assigned To Examiner

Sep 8, 2020

New Application Office Supplied Data Entered In Tram

Aug 11, 2020

New Application Entered In Tram